Publicaciones en colaboración con investigadores/as de University of Alberta (4)

2024

  1. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    New England Journal of Medicine, Vol. 390, Núm. 15, pp. 1394-1407

2023

  1. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    Nature Medicine, Vol. 29, Núm. 9, pp. 2358-2365

  2. Semaglutide in Patients With Obesity and Heart Failure Across Mildly Reduced or Preserved Ejection Fraction

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2087-2096

  3. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

    New England Journal of Medicine, Vol. 389, Núm. 12, pp. 1069-1084